Company / Current Assets
BioLife Solutions, Inc. Current Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$136.6M
FY2025
5-year range
$120.6M / $148.8M
FY2021-FY2025
Trend
-8.2%
vs FY2024
Sector context
#159 of 165
Health Care
What the data says
Among 165 Health Care companies, BioLife Solutions, Inc. is in the bottom 4% for current assets. Current Assets has fluctuated over the past 10 years, ranging from $5M in FY2016 to $149M in FY2024.
Based on SEC 10-K filings.
$137M in FY2025 with a 5-year CAGR of +3.5%.
Improved from $121M to $137M over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- -0.5%
- 5-Year CAGR
- +3.5%
- 10-Year CAGR
- -
Sector benchmark
Bottom 4% in Health CareTop 96% of 165This company $136.6M Sector average $5.2B
▼
-97.4% below sector average
Key checks
Key Insights
- 5-year CAGR of +3.5%, indicating consistent growth.
- In FY2025, current assets decreased 8.2% year-over-year.
- Ranks #159 out of 165 companies in the Health Care sector.
- Peak current assets was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score 4.67 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $136.6M | -8.2% |
| FY2024 | $148.8M | +23.3% |
| FY2023 | $120.6M | -12.9% |
| FY2022 | $138.5M | +9.8% |
| FY2021 | $126.1M | +9.9% |
| FY2020 | $114.7M | +375.7% |
| FY2019 | $24.1M | +135.4% |
| FY2018 | $10.2M | +3.2% |
| FY2017 | $9.9M | +114.6% |
| FY2016 | $4.6M | -33.6% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026